You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy or Radiotherapy for Resectable Pancreatic Adenocarcinoma

Version: 2-23 Version 2 ID: 2-23 Oct 2015
Type of Content: Guidelines & Advice, Clinical
Document Status: Education and Information
Gastrointestinal Cancer Disease Site Group

Patient Population

Adult patients with resectable pancreatic adenocarcinoma for whom a pancreatectomy is planned.

Research Question(s)

Should patients with resectable adenocarcinoma of the exocrine pancreas receive preoperative or postoperative chemotherapy and/or radiation?

Outcomes of interest were overall survival, quality of life, and adverse effects.

pdf download Summary (PDF) (399.21 KB)